InflaRx N.V. announced that Mr. Richard Brudnick has been appointed as interim Non-Executive Director to the Board of Directors of company. Mr. Brudnick has substantial experience in the biotechnology and healthcare industry and is currently serving as Chief Business Officer and Head of Strategy for Codiak BioSciences. He brings extensive commercial and business development expertise to InflaRx as the Company’s pipeline progresses towards commercialization. The confirmed appointment of Mr. Brudnick as a Non-Executive Director of the Board is subject to the approval at the annual general meeting of shareholders in May 2019. Prior to such time, Mr. Brudnick will attend board meetings as a non-voting observer. Richard Brudnick currently serves as Chief Business Officer and Head of Strategy for Codiak BioSciences. Prior to joining Codiak, Mr. Brudnick was Executive Vice President of Business Development and Alliance Management at Bioverativ Inc.